ABOUT THIS EVENT

Landos Biopharma, Inc. (Nasdaq: LABP), a clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune disease, rings the Nasdaq Opening Bell remotely from across the country.

Josep Bassaganya-Riera, PhD, Chairman, President & CEO, rings the Opening Bell alongside the Company’s team in a virtual bell ringing ceremony.